Showing results (191-200 of 226) with videos related to
Sort By:
Pageof 23
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2019
Mobilization of Leukemic Cells Using Plerixafor as Part of a Myeloablative Preparative Regimen for Patients with Acute Myelogenous Leukemia Undergoing Allografting: Assessment of Safety and TolerabilityFotios V Michelis, David W Hedley, Sonal Malhotra, et al.Blood|August 1, 1989
A possible autocrine role for interleukin-6 in two lymphoma cell linesC Yee, A Biondi, X H Wang, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|September 6, 2024
Development of the coreHEM mental health patient-reported outcome measure - A novel mental health outlook measure for people with haemophiliaElizabeth Clearfield, Hsing-Yuan Chang, Ellen M Janssen, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2016
Myeloablative versus Reduced-Intensity Conditioning in Patients with Myeloid Malignancies: A Propensity Score-Matched AnalysisHassan Sibai, Umberto Falcone, Uday Deotare, et al.British Journal of Haematology|June 2, 2012
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukaemia with imatinib combined with a paediatric-based protocolSanthosh Thyagu, Mark D Minden, Vikas Gupta, et al.Annals of Hematology|February 20, 2017
Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHDJoon Ho Moon, Nada Hamad, Sang Kyun Sohn, et al.Clinical Lymphoma, Myeloma & Leukemia|November 21, 2013
A comparison of long-term outcomes of donor lymphocyte infusions and tyrosine kinase inhibitors in patients with relapsed CML after allogeneic hematopoietic cell transplantationMohamed Shanavas, Hans A Messner, Suzanne Kamel-Reid, et al.Bone Marrow Transplantation|January 23, 1999
Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspectiveS Couban, G Dranitsaris, P Andreou, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2014
Incidence, risk factors, and long-term outcomes of sclerotic graft-versus-host disease after allogeneic hematopoietic cell transplantationJieun Uhm, Nada Hamad, Elizabeth M Shin, et al.Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
Modified EBMT Pretransplant Risk Score Can Identify Favorable-risk Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for AML, Not Identified by the HCT-CI ScoreFotios V Michelis, Hans A Messner, Jieun Uhm, et al.Pageof 23